96
Participants
Start Date
January 31, 2016
Primary Completion Date
October 31, 2018
Study Completion Date
October 31, 2018
Lactobacillus rhamnosus GG
For the intravesicular Lactobacillus instillation, participants will be instructed to mix the contents of 1 Lactobacillus capsule into 45 cc sterile 0.9% saline.5,6 After mixing, participants will draw up the 45 cc of the liquid Lactobacillus mixture into a 60cc catheter tip syringe and instill via the intermittent catheter after the last catheterization prior to going to bed. Participants will receive 10 Lactobacillus GG tabs at the beginning of treatment phase. At the end of each month, the coordinator or RA will ask how many remaining tablets the participant has, and if needed dispense the next supply of 10 tablets Participants will be instructed to complete the USQ-NB weekly.
Children's National Medical Center, Washington D.C.
MedStar National Rehabilitation Hospital, Washington D.C.
Lead Sponsor
Collaborators (1)
Patient-Centered Outcomes Research Institute
OTHER
Georgetown University
OTHER
Children's National Research Institute
OTHER
Medstar Health Research Institute
OTHER